https://www.avient.com/sites/default/files/2024-12/2024 Avient Executive Bios_Philip Clark.pdf
https://www.avient.com/sites/default/files/2024-12/2024 Avient Executive Bios_Kristen Gajewski.pdf
https://www.avient.com/sites/default/files/2024-12/2024 Avient Executive Bios_Holger Kronimus.pdf
https://www.avient.com/sites/default/files/2024-12/2024 Avient Executive Bios_Kyle Rose.pdf
https://www.avient.com/sites/default/files/2024-12/2024 Avient Executive Bios Leslie Sequeira.pdf
https://www.avient.com/sites/default/files/2024-12/2024 Avient Executive Bios_John Midea.pdf
https://www.avient.com/content/first-quarter-2024-results-0
Earnings webcast recording, slide presentation and press release available at https://www.avient.com/investors/events-presentations.
1 Company’s non-GAAP reconciliation can be found at the press release here.
https://www.avient.com/content/third-quarter-2024-results
Earnings webcast recording, slide presentation, and press release available at https://www.avient.com/investors/events-presentations.
1 Company’s non-GAAP reconciliation can be found at the press release here.
https://www.avient.com/content/second-quarter-2024-results
Earnings webcast recording, slide presentation and press release available at https://www.avient.com/investors/events-presentations.
1 Company’s non-GAAP reconciliation can be found at the press release here.
https://www.avient.com/news/avient-highlight-bio-based-polymer-solutions-pharmapack-2024
Like other Mevopur products, they are formulated with raw materials tested to ISO 10993-1 and USP , European Pharmacopeia 3.1.3 and 3.1.5, USP and ICH Q3D.
For more information, visit https://www.avient.com.
